Sun BioPharma, Inc.·4

Jun 28, 12:30 PM ET

Sun BioPharma, Inc. 4

4 · Sun BioPharma, Inc. · Filed Jun 28, 2016

Insider Transaction Report

Form 4
Period: 2016-06-24
KAYSEN DAVID B
President and CEO
Transactions
  • Purchase

    Warrant (right to buy)

    2016-06-24+25,00025,000 total
    Exercise: $1.50From: 2016-06-24Exp: 2021-06-24Common Stock (25,000 underlying)
  • Purchase

    Common Stock

    2016-06-24+50,00050,000 total
Footnotes (1)
  • [F1]Reported securities purchased as one share of common stock and one warrant to purchase one-half share of common stock for a combined price of $1.00 per "unit."

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    JUNE 2016 PIPE FORM 4